Free Shipping on All Orders $75 Or More! Ends January 31st.

Your Trusted Brand for Over 35 Years

Life Extension Magazine

Potential Danger Of Calcium Supplements

By William Faloon


1. Li K, Kaaks R, Linseisen J, Rohrmann S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study. Heart. 2012 Jun;98(12):920-5.

2. Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A. Mg2+Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist induced responsiveness of blood vessels. Can J Physiol Pharmacol. 1987 Apr;65(4):729-45.

3. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 2002 Sep;238(1-2):163-79.

4. Chacko SA, Song Y, Nathan L, et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care. 2010 Feb;33(2):304-10.

5. Ferrè S, Baldoli E, Leidi M, Maier JA. Magnesium deficiency promotes apro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. Biochim Biophys Acta. 2010 Nov;1802(11):952-8.

6. Maier JA. Endothelial cells and magnesium: implications in atherosclerosis. Clin Sci (Lond). 2012 May;122(9):397-407.

7. Pen JX, Li L, Wang X, Zhang YH, Li XF, Wu SY. The effect of the magnesium supplementation on vascular calcification in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2012 Jan;28(1):20-3.

8. Available at: Accessed June 6, 2012.

9. Key TJ, Appleby PN, Spencer EA, Roddam AW, Neale RE, Allen NE. Calcium, diet and fracture risk: a prospective study of 1898 incident fractures among 34 696 British women and men. Public Health Nutr. 2007 Nov;10(11):1314-20. Epub 2007 Mar 19.

10. Hsu HH, Culley NC. Effects of dietary calcium on atherosclerosis, aortic calcification, and icterus in rabbits fed a supplemental cholesterol diet. Lipids Health Dis. 2006 Jun 23;5:16.

11. Heaney RP. Calcium needs of the elderly to reduce fracture risk. J Am Coll Nutr. 2001 Apr;20(2 Suppl):192S-7S.

12. Zhang W, Iso H, Ohira T, Date C, Tamakoshi A. Associations of dietary magnesium intake with mortality from cardiovascular disease: the JACC study. Atherosclerosis. 2012 Apr;221(2):587-95.

13. Beulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, Witteman JC, Grobbee DE, van der Schouw YT. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009 Apr;203(2):489-93.

14. Scheuner MT, Setodji CM, Pankow JS, Blumenthal RS, Keeler E. General Cardiovascular Risk Profile identifies advanced coronary artery calcium and is improved by family history: the multiethnic study of atherosclerosis. Circ Cardiovasc Genet. 2010 Feb;3(1):97-105. Epub 2009 Dec 14.

15. Gast GC, de Roos NM, Sluijs I, et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 2009; Sep;19(7):504-10.

16. Mathers TW, Beckstrand RL. Oral magnesium supplementation in adults with coronary heart disease or coronary heart disease risk. J Am Acad Nurse Pract. 2009 21(12):651-7.

17. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004 Nov;134(11):3100-5.

18. Larsson SC, Orsini N, Wolk A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr. 2012 Feb;95(2):362-6.

19. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2009 Jun 15;169(12):1437-44.

20. Cojocaru IM, Cojocaru M, Burcin C, Atanasiu NA. Serum magnesium in patients with acute ischemic stroke. Rom J Intern Med. 2007;45(3):269-73.

21. Downey PA, Siegel MI. Bone biology and the clinical implications for osteoporosis. Phys Ther. 2006 Jan;86(1):77-91.

22. Sato Y, Honda Y, Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone. 1998 Sep;23(3):291-6.

23. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood. 2007 Apr 1;109(7):2823-31.

24. Howe AM, Webster WS. Warfarin exposure and calcification of the arterial system in the rat. Int J Exp Pathol. 2000 Feb;81(1):51-6.

25. Rennenberg RJ, de Leeuw PW, Kessels AG, et al. Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur J Clin Invest. 2010 Apr;40(4):344-9.

26. Weijs B, Blaauw Y, Rennenberg RJ, et al. Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J. 2011 Oct;32(20):2555-62.

27. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006 Jun 26;166(12):1256-61.

28. Zittermann A. Effects of vitamin K on calcium and bone metabolism. Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):483-7.

29. Je SH, Joo NS, Choi BH, et al. Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old. J Korean Med Sci. 2011 Aug;26(8):1093-8.

30. Hidaka T, Hasegawa T, Fujimura M, Sakai M, Saito S. Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: effects of concomitant administration of vitamin K(2). J Bone Miner Metab. 2002 20(4):235-9.

31. Adams J, Pepping J. Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health Syst Pharm. 2005 Aug 1;62(15):1574-81.

32. Bügel S. Vitamin K and bone health. Proc Nutr Soc. 2003 Nov;62(4):839-43.

33. Cranenburg EC, Vermeer C, Koos R, et al. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res. 2008 45(5):427-36.

34. Schurgers LJ, Dissel PE, Spronk HM, et al. Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol. 2001 90(Suppl):357-63.

35. Amizuka N, Li M, Guo Y, Liu Z, Suzuki R, Yamamoto T. Biological effects of vitamin K2 on bone quality. Clin Calcium. 2009 Dec;19(12):1788-96.

36. Spronk HM, et al, Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun. 2001 Nov 30;289(2):485-90.

37. Chatrou ML, Reutelingsperger CP, Schurgers LJ. Role of vitamin K-dependent proteins in the arterial vessel wall. Hamostaseologie. 2011 Nov;31(4):251-7.

38. Knapen MHJ, Hamulyak K, Vermeer C. The effect of vitamin K supplementation on cir- culating osteocalcin (bone Gla protein) and urinary calcium extraction. Ann Intern Med. 1989 Dec 15;111(12);1001-5.

39. Sugiyama T, Kawai S. Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab. 2001;19(3):146-9.

40. Yasui T, Miyatani Y, Tomita J, et al. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women. Gynecol Endocrinol. 2006 Aug;22(8):455-9.

41. Iwamoto J, Sato Y, Takeda T, Matsumoto H. High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature. Nutr Res. 2009 April 29(4):221-8.

42. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000 March 15(3):515-21.

43. Miki T, Nakatsuka K, Naka H, et al. Vitamin K(2) (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis. J Bone Miner Metab. 2003 21(3):161-5.

44. Tsugawa N, Shiraki M, Suhara Y, et al. Vitamin K status of healthy Japanese women: age-related vitamin K requirement for gamma-carboxylation of osteocalcin. Am J Clin Nutr. 2006 Feb;83(2):380-6.

45. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997 Mar 6;386(6620):78-81.

46. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int. 1996 Nov;59(5):352-6.

47. Jie KS, Bots ML, Vermeer C, Witteman JC, Grobbee DE. Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. Atherosclerosis. 1995 Jul;116(1):117-23.

48. Available at: Accessed May 28, 2012.

49. Available at: Accessed June 6, 2012.

50. Available at: Accessed May 28, 2012.

51. Available at: Accessed June 6, 2012.

52. Available at: Accessed May 29, 2012.

53. Available at: Accessed May 28, 2012.

54. Available at: Accessed May 29, 2012.

55. Available at: Accessed May 30, 2012.

56. Available at: Accessed May 31, 2012.

57. Available at: Accessed May 31, 2012.

58. Available at: Accessed May 31, 2012.

59. Available at: Accessed May 31, 2012.

60. Available at: Accessed May 31, 2012.

61. Available at: Accessed May 31, 2012.

62. Available at: Accessed May 31, 2012.

63. Available at: Accessed May 31, 2012.

64. Available at: Accessed May 31, 2012.

65. Available at: Accessed May 31, 2012.

66. Available at: Accessed May 31, 2012.

67. Available at: Accessed June 6, 2012